Halt Medical has announced it has received FDA clearance for a new system to treat uterine fibroids, according to a news release.
The Acessa system is designed for use in a minimally invasive same-day surgery procedure where a slender handpiece is used to deliver radiofrequency energy to the fibroid. After treatment, the fibroid is re-absorbed by the surrounding tissue.
"With compelling results from three clinical studies, we have been anticipating this clearance from the FDA," said Russ DeLonzor, Halt's president and chief operating officer, in the release. "We've been expanding our manufacturing operations near San Francisco and are ready to meet the increased demand for Acessa from doctors in the United States and abroad."
Acessa is already in use at medical centers in Canada and Europe.
Halt Medical is headquartered in Brentwood, Calif.
Related Articles on FDA Clearances:
Blue Belt Technologies Receives FDA Clearance for Unicondylar Knee Replacement Surgery
Precision Spine Receives FDA Clearance for Minimally Invasive Access System
LENSAR Cataract Laser System Receives FDA Clearance for Corneal Incisions